arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

ALUMIS INC.

ALMS
$5.83 ▼ -0.72 (-11.05%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
4 Visible periods
21 Metrics
Peer-ranked Benchmarks
Price Chart
31
Health
Poor
Bearish
auto_awesome

Analytical Summary

ALUMIS INC. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $495.7M
Dividend Yield —
Revenue Growth —
Op. Margin —
ROIC -145.5% ↘
FCF / Share $-4.35 ↗
Trailing P/E —
Price / Book 1.7x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

4-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Net Income Profit after all expenses
$-243.32M
↑ +17.3% —
FCF / Share Free cash flow per share
$-4.35
↑ +52.0% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
11
Cash Quality ↑
80

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 4 years · 15 quarters